BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 10843165)

  • 1. Changes in plasma low-density lipoprotein (LDL)- and high-density lipoprotein cholesterol in hypo- and hyperthyroid patients are related to changes in free thyroxine, not to polymorphisms in LDL receptor or cholesterol ester transfer protein genes.
    Diekman MJ; Anghelescu N; Endert E; Bakker O; Wiersinga WM
    J Clin Endocrinol Metab; 2000 May; 85(5):1857-62. PubMed ID: 10843165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cholesteryl ester transfer protein activity in hyper- and hypothyroidism.
    Tan KC; Shiu SW; Kung AW
    J Clin Endocrinol Metab; 1998 Jan; 83(1):140-3. PubMed ID: 9435431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene.
    Wiseman SA; Powell JT; Humphries SE; Press M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):108-12. PubMed ID: 8100826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid hormone increases plasma cholesteryl ester transfer protein activity and plasma high-density lipoprotein removal rate in transgenic mice.
    Berti JA; Amaral ME; Boschero AC; Nunes VS; Harada LM; Castilho LN; Oliveira HC
    Metabolism; 2001 May; 50(5):530-6. PubMed ID: 11319713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and apolipoprotein B plasma concentrations in hypothyroid, euthyroid, and hyperthyroid subjects.
    de Bruin TW; van Barlingen H; van Linde-Sibenius Trip M; van Vuurst de Vries AR; Akveld MJ; Erkelens DW
    J Clin Endocrinol Metab; 1993 Jan; 76(1):121-6. PubMed ID: 8421075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment.
    Tzotzas T; Krassas GE; Konstantinidis T; Bougoulia M
    Thyroid; 2000 Sep; 10(9):803-8. PubMed ID: 11041458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased oxidizability of low-density lipoproteins in hypothyroidism.
    Diekman T; Demacker PN; Kastelein JJ; Stalenhoef AF; Wiersinga WM
    J Clin Endocrinol Metab; 1998 May; 83(5):1752-5. PubMed ID: 9589687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thyroid dysfunction on high-density lipoprotein subfraction metabolism: roles of hepatic lipase and cholesteryl ester transfer protein.
    Tan KC; Shiu SW; Kung AW
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2921-4. PubMed ID: 9709970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in serum lipoprotein(a) and lipids during treatment of hyperthyroidism.
    Kung AW; Pang RW; Lauder I; Lam KS; Janus ED
    Clin Chem; 1995 Feb; 41(2):226-31. PubMed ID: 7874776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age and gender substantially influence the relationship between thyroid status and the lipoprotein profile: results from a large cross-sectional study.
    Tognini S; Polini A; Pasqualetti G; Ursino S; Caraccio N; Ferdeghini M; Monzani F
    Thyroid; 2012 Nov; 22(11):1096-103. PubMed ID: 23050788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
    Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
    J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of hypothyroidism and replacement therapy on cholesteryl ester transfer.
    Ritter MC; Kannan CR; Bagdade JD
    J Clin Endocrinol Metab; 1996 Feb; 81(2):797-800. PubMed ID: 8636306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of levo-thyroxine replacement on non-high-density lipoprotein cholesterol in hypothyroid patients.
    Ito M; Arishima T; Kudo T; Nishihara E; Ohye H; Kubota S; Fukata S; Amino N; Kuma K; Sasaki I; Hiraiwa T; Hanafusa T; Takamatsu J; Miyauchi A
    J Clin Endocrinol Metab; 2007 Feb; 92(2):608-11. PubMed ID: 17148561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cholesteryl ester transfer protein activity is high in infants and is not affected by thyroid hormones.
    Asami T; Wada M; Uchiyama M
    Metabolism; 2000 Sep; 49(9):1176-9. PubMed ID: 11016900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term thyroid replacement therapy and levels of lipoprotein(a) and other lipoproteins.
    Pazos F; Alvarez JJ; Rubiés-Prat J; Varela C; Lasunción MA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):562-6. PubMed ID: 7852521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Variation in high density lipoprotein cholesterol during treatment of thyroid gland diseases].
    Barbier R; Paffoy JC; Venard-Sassolas A; Berthezene F
    Diabete Metab; 1980 Sep; 6(3):213-7. PubMed ID: 7439494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.
    Danese MD; Ladenson PW; Meinert CL; Powe NR
    J Clin Endocrinol Metab; 2000 Sep; 85(9):2993-3001. PubMed ID: 10999775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid and lipoprotein pattern in thyroid dysfunction and the effect of therapy.
    Aviram M; Luboshitzky R; Brook JG
    Clin Biochem; 1982 Feb; 15(1):62-6. PubMed ID: 7067079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma high density lipoprotein cholesterol in thyroid disease.
    Agdeppa D; Macaron C; Mallik T; Schnuda ND
    J Clin Endocrinol Metab; 1979 Nov; 49(5):726-9. PubMed ID: 226559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.